Effective at the close of business on Sept. 1, 2026, the common shares of XORTX Therapeutics Inc. will be delisted from the TSX Venture Exchange at the request of the company. The company will continue to trade on the Nasdaq Stock Market.

For more information, please refer to the company's news release dated June 12, 2026, and Aug. 28, 2026.